Herbs (Global Traditional) · Southeast Asian
Euphorbia (Euphorbia hirta) (Euphorbia hirta)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Euphorbia hirta is a medicinal plant containing flavonoids, tannins, and phenolic compounds that may support anxiety reduction through GABA-A receptor modulation. The herb demonstrates anti-inflammatory properties by inhibiting nitric oxide production in immune cells.
Euphorbia hirta is a pantropical annual herbaceous plant from the Euphorbiaceae family, commonly known as asthma weed, native to regions including Africa, Asia, and Australia. The whole plant, particularly aerial parts (leaves and stems), is typically extracted using solvents like ethanol, methanol, or n-hexane to obtain bioactive components including flavonoids, polyphenols, and terpenoids.
No human clinical trials, RCTs, or meta-analyses were identified for Euphorbia hirta. Current evidence is limited to preclinical animal studies showing anxiolytic effects at 200 mg/kg oral dosing in rats and in vitro studies demonstrating anti-inflammatory and anticancer properties at 100-200 µg/mL concentrations.
No clinically studied human dosages available. Animal studies used 200 mg/kg orally for anxiolytic effects and up to 1000 mg/kg daily showed no toxicity in 90-day rat studies. In vitro concentrations ranged from 100-200 µg/mL for biological activity. Consult a healthcare provider before starting any new supplement.
Euphorbia hirta is primarily used as a medicinal herb rather than a food source, so conventional macronutrient profiling is limited. Key bioactive compounds include: **Flavonoids** — quercitrin (~0.5–1.2% dry weight), myricitrin, rutin, and quercetin glycosides, which contribute to its anti-inflammatory and antioxidant activities; **Polyphenols** — gallic acid, ellagic acid, and caffeic acid derivatives (total phenolic content approximately 45–85 mg GAE/g dry extract depending on solvent); **Terpenes** — β-amyrin, taraxerol, and friedelin (triterpenoids found in stem and leaf tissue); **Tannins** — hydrolysable tannins including euphorbins A, B, and C (condensed tannin content ~3–6% dry weight), contributing astringent properties; **Alkaloids** — trace amounts detected but not fully characterized; **Shikimic acid** — present in notable quantities (~0.1–0.3% dry weight); **Sterols** — β-sitosterol and campesterol. **Mineral content** (per 100 g dry leaf): calcium (~1,200–1,800 mg), potassium (~1,500–2,100 mg), magnesium (~350–500 mg), iron (~15–30 mg), zinc (~3–8 mg), and manganese (~5–12 mg). **Crude protein**: approximately 10–14% of dry weight. **Crude fiber**: approximately 12–18% of dry weight. **Essential fatty acids**: leaves contain small amounts of linoleic and α-linolenic acid. **Latex compounds**: the milky sap contains diterpene esters (ingenol and phorbol derivatives) which are biologically active but potentially irritant. **Bioavailability notes**: Flavonoid glycosides (quercitrin, myricitrin) have moderate oral bioavailability due to glycosylation enhancing water solubility; however, tannin content may reduce protein and mineral absorption if consumed orally. Aqueous and ethanolic extracts show differing compound profiles — aqueous extracts are richer in polyphenols and tannins, while ethanolic extracts concentrate flavonoids and terpenoids more effectively. Most pharmacological studies use doses standardized to total phenolic or flavonoid content rather than crude weight.
Euphorbia hirta's flavonoids and phenolic compounds appear to modulate GABA-A receptors in the central nervous system, potentially reducing anxiety-like behaviors. The plant's anti-inflammatory effects involve inhibition of nitric oxide synthase in activated macrophages, reducing inflammatory mediator production.
Limited preclinical studies show Euphorbia hirta extract at 200 mg/kg reduced anxiety behaviors in rat stress models through GABA-A receptor mechanisms. In vitro studies demonstrate anti-inflammatory activity with 200 µg/mL concentrations inhibiting nitric oxide production in RAW264.7 macrophage cells. Currently, no human clinical trials have been published evaluating safety or efficacy. Evidence remains preliminary and confined to laboratory studies.
Safety data for Euphorbia hirta is limited, with no established safe dosage ranges for human consumption. The plant may theoretically interact with GABA-ergic medications like benzodiazepines or anticonvulsants due to its GABA-A receptor activity. Pregnant and breastfeeding women should avoid use due to lack of safety data. Potential side effects and long-term safety profile remain unknown without human studies.
